Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.1200 (-4.67%) ($6.0700 - $6.6000) on Mon. Sep. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 46 | Latest Price | $6.1200(-4.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -3.3% a day on average for past five trading days. | Weekly Trend | CEMI advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) UNG(21%) XAR(8%) USO(7%) IGOV(6%) IWN(6%) | Factors Impacting CEMI price | CEMI will decline at least -1.65% in a week (0% probabilities). URA(-8%) JNK(-6%) IPO(-6%) HYG(-5%) BLOK(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | 0 () | Intraday Trend | -5.3% | | | |
|
Resistance Level | $6.55 | 5 Day Moving Average | $6.75(-9.33%) | 10 Day Moving Average | $6.87(-10.92%) | 20 Day Moving Average | $6.55(-6.56%) | To recent high | -15.6% | To recent low | 21.4% | Market Cap | $123m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |